Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 65% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Edwards Lifesciences TAVR cuts risk of death or heart failure events by 33% in moderate aortic stenosis trial

By Public Technologies
  • Edwards Lifesciences’ PROGRESS trial found transcatheter aortic valve replacement superior to clinical surveillance in moderate aortic stenosis patients with at-risk features.
  • Treatment reduced the combined risk of death or heart failure events over two years; mortality alone was similar between groups.
  • Patients receiving treatment had fewer heart failure hospitalizations and improved quality of life, with no deaths or disabling strokes at 30 days.
  • Results were presented at Transcatheter Cardiovascular Therapeutics 2026 and simultaneously published in The New England Journal of Medicine.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edwards Lifesciences Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 202611021240BIZWIRE_USPR_____20261102_BW440960) on November 02, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.